Text Size

Tai Chi Exercise in Patients With COPD

This study has been completed.
Sponsor:
Information provided by:
National Center for Complementary and Alternative Medicine (NCCAM)
ClinicalTrials.gov Identifier:
NCT01027338
First received: December 4, 2009
Last updated: NA
Last verified: December 2009
History: No changes posted
  Purpose

This is a pilot randomized controlled trial of feasibililty and prelimnary effects of a 12 week tai chi intervention vs. usual care in patients with chronic obstructive pulmonary disease


Condition Intervention Phase
COPD
 Other: Tai chi exercise
 Phase 1

Study Type: Interventional
Official Title: Tai Chi Exercise in Patients With Chronic Obstructive Pulmonary Disease

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by National Center for Complementary and Alternative Medicine (NCCAM):

Primary Outcome Measures:
  • study feasibility [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • quality of life [ Designated as safety issue: No ]
  • exercise capacity [ Designated as safety issue: No ]

Arms Assigned Interventions
Experimental: Tai Chi Exercise Other: Tai chi exercise
No Intervention: Usual Care

  Eligibility

Ages Eligible for Study:   45 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • physician diagnosis of COPD
  • FEV1<65% of predicted and FEV1/FVC<70% of predicted
  • ≥45 years old

Exclusion Criteria:

  • COPD exacerbation requiring ER visit or hospitalization within past month
  • planned major pulmonary intervention in coming 3 months
  • severe peripheral vascular disease/claudication or other physical condition precluding walk test
  • inability to perform bicycle ergometry
  • severe cognitive dysfunction (MMSE ≤ 24)
  • inability to speak English
  • current participation in a pulmonary rehabilitation or regular practice of tai chi
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01027338

Locations
United States, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215
Sponsors and Collaborators
National Center for Complementary and Alternative Medicine (NCCAM)
Investigators
Principal Investigator: Gloria Y Yeh, MD, MPH Beth Israel Deaconess Medical Center
  More Information

No publications provided

Responsible Party: Russell Phillips, MD, Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier: NCT01027338     History of Changes
Other Study ID Numbers: K24AT000589
Study First Received: December 4, 2009
Last Updated: December 4, 2009
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Pulmonary Disease, Chronic Obstructive
Lung Diseases, Obstructive
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on May 16, 2013